We are delighted to announce that two new Trustees will be joining the NCRI Board. Dr Iain Frame, Director of Research at…
Interview with Dr Clare Verrill, member of the NCRI’s CM-Path
Dr Clare Verrill has recently been appointed the lead of workstream 4 (Technology and Informatics) within the Clinical Molecular Pathology…
Interview with Dr Jervoise Andreyev, member of NCRI LWBC Group
Dr Jervoise Andreyev is a steering group member for the James Lind Alliance Priority Setting Partnership within our Living With and…
The NCRI launches new five-year strategy to accelerate progress in cancer research
The National Cancer Research Institute (NCRI) launches its new five-year strategy today (Tuesday) to accelerate progress in cancer research through…
New NCRI Living With and Beyond Cancer initiative
NCRI has formally launched its new initiative on living with and beyond cancer research on 25 April 2017. Working with…
NCRI Director Karen Kennedy talks about the new NCRI strategy
Cancer presents vast challenges that will not be overcome by a single organisation working in isolation. In the UK alone, 360,000 people are diagnosed with cancer each year. Research is driving progress in early diagnosis and treatments, and now more than half of those diagnosed with cancer live for more than ten years. But we need to do more, and collaboration and partnership working within the cancer research community are now more important than ever.…
Interview with Angharad Kerr, Health and Care Research Wales
This month we interview Angharad Kerr at Health and Care Research Wales about what her roles entail and the importance of the NCRI in supporting collaborative working.…
Interview with Dr Ian Lewis, Head of Clinical Research Groups
Dr Ian Lewis has recently joined the NCRI as Head of Clinical Research Groups as a maternity cover. In our…
Interview with Dr Lorna Fern, Research and Development Co-ordinator at NCRI
Dr Lorna Fern Research and Development Co-ordinator at NCRI recently reached a milestone – she has worked for NCRI for…
Marker for aggressive prostate cancer doubles-up as a drug target
Researchers have discovered that a marker found on aggressive prostate cancer cells could also be used as a way to…
Researchers find key to drug resistant bowel cancer
Blocking a molecule could bypass bowel cancer’s defence against the drug cetuximab, according to new research* presented at the National…
One in six women diagnosed with breast cancer have a symptom other than a lump
Around one in six women (17 per cent) diagnosed with breast cancer go to their doctor with a symptom other…